Grants and Contracts

Grants and Contracts per year 2000 2009 2012 2013 2014 2025

• 6 Active
• 74 Finished

Grants and Contracts per year

Search results

• Finished

  A Phase 3, 2-Part, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Pharmacokinetics, Efficacy and Safety of VX-770 in Subjects with Cystic Fibrosis and the G551D Mutation

  Anstead, M. & Kanga, J.

  Vertex Pharmaceuticals Inc

  8/26/09 → 8/25/10

  Project: Research project

• A Phase 3, 2-Part, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Pharmacokinetics, Efficacy and Safety of VX-770 in Subjects aged 6-11 with Cystic Fibrosis and the G551D Mutation

  Kanga, J.

  Vertex Pharmaceuticals Inc

  8/26/09 → 8/25/10

  Project: Research project

• Cystic Fibrosis Center Program

  Kanga, J., Anstead, M., Danov, Z. & Hayes, D.

  Cystic Fibrosis Foundation

  7/1/09 → 6/30/10

  Project: Research project

  • Program 100%
  • Cystic Fibrosis 100%
  • Hospital Service 100%
  • Schools 50%
  • Organizations 50%

• The EPIC Observational Study: Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa (Pa) Airway Infection in Young Patients with Cystic Fibrosis

  Kanga, J.

  Seattle Childrens Research Institute

  4/1/09 → 3/31/14

  Project: Research project

  • Observational Study 100%
  • Therapeutic Procedure 100%
  • Patient with Cystic Fibrosis 100%
  • Antimicrobial Therapy 100%
  • Respiratory Tract Infection 100%

• Therapeutics Development Center

  Anstead, M., Kanga, J. & Kuhn, R.

  Cystic Fibrosis Foundation

  1/1/09 → 12/31/11

  Project: Research project

• Therapeutics Development Center

  Anstead, M., Kanga, J. & Kuhn, R.

  Cystic Fibrosis Foundation

  1/1/09 → 12/31/12

  Project: Research project

  • Combination Therapy 100%
  • Development 100%
  • Clinical Research 100%
  • Research 100%
  • Clinical Study 75%

• Therapeutics Development Center

  Kanga, J., Anstead, M., Danov, Z. & Kuhn, R.

  Cystic Fibrosis Foundation

  1/1/09 → 12/31/13

  Project: Research project

  • Combination Therapy 100%
  • Development 100%
  • Clinical Research 100%
  • Research 100%
  • Clinical Study 75%

• Therapeutics Development Network 2014

  Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.

  Cystic Fibrosis Foundation

  1/1/09 → 12/31/14

  Project: Research project

  • Site 100%
  • Investigation 100%
  • Network 100%
  • Patient 100%
  • Combination Therapy 100%

• University of Kentucky Therapeutic Development Center

  Anstead, M., Kanga, J. & Kuhn, R.

  Cystic Fibrosis Foundation

  1/1/09 → 12/31/09

  Project: Research project

  • Kentucky 100%
  • University 100%
  • Research 100%
  • Development 100%
  • Clinical Research 100%

• Therapeutics Development Center

  Anstead, M., Kanga, J. & Kuhn, R.

  Cystic Fibrosis Foundation

  1/1/09 → 12/31/10

  Project: Research project

  • Combination Therapy 100%
  • Development 100%

• A Phase 3, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Denufosol Tetrasodium Inhalation Solution in Patients with Cystic Fibrosis Lung Disease and FEV, => 75% but =<110% Predicted

  Kanga, J.

  Inspire Pharmaceuticals

  8/1/08 → 4/30/11

  Project: Research project

• Cystic Fibrosis Center Program

  Kanga, J. & Anstead, M.

  Cystic Fibrosis Foundation

  7/1/08 → 6/30/09

  Project: Research project

  • Cystic Fibrosis 100%

• A Phase III Randomized Double-Blind Placebo-Controlled Clinnical Study Evaluating the Efficacy and Safety of ALTU-135 Treatment in Patients with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency

  Kanga, J.

  Altus Pharmaceuticals Inc.

  2/19/08 → 8/31/08

  Project: Research project

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects with Severe Lung Disease

  Kanga, J.

  Genentech Inc

  8/16/07 → 12/31/09

  Project: Research project

• Cystic Fibrosis Center Program

  Kanga, J. & Anstead, M.

  Cystic Fibrosis Foundation

  7/1/07 → 6/30/08

  Project: Research project

• A Multicenter, Double-Blind, Palcebo Controlled, Randomized, Efficacy and Safety Study of Denufosol Tetrasodium (INS37217) Inhalation Solution in Patients with Mild Cystic Fibrosis Lung Disease

  Kanga, J.

  Inspire Pharmaceuticals

  2/1/07 → 7/31/09

  Project: Research project

• A Multicenter, Randomized, Double-Blind, Crossover Study to Compare the Safety and Efficacy of Ultrase MT20 to Placebo for the Correction of Steatorrhea in Patients with Cystic Fibrosis

  Kanga, J.

  Axcan Pharma Inc.

  1/1/07 → 12/31/08

  Project: Research project

• Cystic Fibrosis Research TDN Grant

  Kanga, J. & Anstead, M.

  Cystic Fibrosis Foundation

  12/1/06 → 12/31/08

  Project: Research project

• Cystic Fibrosis Research TDN Grant

  Kanga, J. & Anstead, M.

  Cystic Fibrosis Foundation

  12/1/06 → 11/30/07

  Project: Research project

• Cystic Fibrosis Center Program

  Kanga, J. & Anstead, M.

  Cystic Fibrosis Foundation

  7/1/06 → 6/30/07

  Project: Research project

• Cystic Fibrosis Center Program

  Kanga, J. & Anstead, M.

  Cystic Fibrosis Foundation

  7/1/05 → 6/30/06

  Project: Research project

  • Cystic Fibrosis 100%

• The EPIC Observational Study: Longitudinal Assessment of Risk Factors for and Impact of Pseudomonoas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children with CF

  Kanga, J.

  Cystic Fibrosis Foundation

  2/1/05 → 9/30/09

  Project: Research project

  • Observational Study 100%
  • Therapeutic Procedure 100%
  • Assessment 100%
  • Child 100%

• Cystic Fibrosis Center Program

  Kanga, J. & Anstead, M.

  Cystic Fibrosis Foundation

  7/1/04 → 6/30/05

  Project: Research project

  • Cystic Fibrosis 100%

• A Phase 2, Randomized, Double Blind, Parallel Dose Ranging Study of Oral TheraCLEC--Total In Cystic Fibrosis Subjects with Exocrine Pancreatic Insufficiency

  Kanga, J.

  Altus Pharmaceuticals Inc.

  6/1/04 → 8/31/05

  Project: Research project

• The EPIC Clinical Study: Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa (Pa) Airway Infection in Young Patients with Cystic Fibrosis

  Kanga, J.

  Cystic Fibrosis Foundation

  3/1/04 → 9/30/09

  Project: Research project

  • Therapeutic Procedure 100%
  • Clinical Study 100%
  • Patient with Cystic Fibrosis 100%
  • Antimicrobial Therapy 100%
  • Respiratory Tract Infection 100%

• Cystic Fibrosis Center Program

  Kanga, J. & Anstead, M.

  Cystic Fibrosis Foundation

  7/1/03 → 6/30/04

  Project: Research project

• Epidemiologic Study of Cystic Fibrosis: A Multicenter Longitudinal Follow Up Study of Patients with Cystic Fibrosis for Monitoring Pulmonary Function, Pulmonary Exacerbations, and the Safety of Long Term Treatment with Pulmozyme Inhalation Solution

  Kanga, J.

  Genentech Inc

  1/1/03 → 3/31/06

  Project: Research project

• Cystic Fibrosis Center Program

  Kanga, J. & Anstead, M.

  Cystic Fibrosis Foundation

  7/1/02 → 6/30/03

  Project: Research project

• Cystic Fibrosis Center Program

  Kanga, J. & Anstead, M.

  Cystic Fibrosis Foundation

  7/1/01 → 6/30/02

  Project: Research project

• Cystic Fibrosis Center Program

  Kanga, J. & Anstead, M.

  Cystic Fibrosis Foundation

  7/1/00 → 12/31/01

  Project: Research project